Differential regulation of cyclic AMP synthesis by estrogen in MCF7 cells

Biochemical and Biophysical Research Communications

Volumn 363, Issue 3, 2007, Pages 616-620

  Chan, Robbie ^a   Wong, Man sau ^a  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

cAMP; Chronic and short term estrogen treatment; Estrogen receptor; G proteins

Indexed keywords

ADENINE; ADENINE NUCLEOTIDE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CHARCOAL; CYCLIC AMP; ESTROGEN; FORSKOLIN; FULVESTRANT; GUANINE NUCLEOTIDE BINDING PROTEIN; PERTUSSIS TOXIN;

ARTICLE; CELL CULTURE; CELL STRAIN MCF 7; COLUMN CHROMATOGRAPHY; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HORMONAL THERAPY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SYNTHESIS;

CELL LINE, TUMOR; CYCLIC AMP; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGENS; FORSKOLIN; HUMANS; INTRACELLULAR FLUID; PERTUSSIS TOXIN; TIME FACTORS;

EID: 34948815148     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.09.005     Document Type: Article

References (29)

1. Green S., and Chambon P. The oestrogen receptor: from perception to mechanism. In: Parker M.G. (Ed). Nuclear Hormone Receptors (1991), Academic Press Ltd., San Diego, CA 15-38
2. Beekman J.M., Allan G.F., Tsai S.Y., Tsai M.-J., and O'Malley B.W. Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain. Mol. Endocrinol. 7 (1993) 1266-1274
3. Pietras R.J., Levin E.R., and Szego C.M. Estrogen receptors and cell signaling. Science 310 (2005) 51-53
4. Sheffield L.G., and Welsch C.W. Cholera-toxin-enhanced growth of human breast cancer cell lines in vitro and in vivo: interaction with estrogen. Int. J. Cancer 36 (1985) 479-483
5. B Silberstein G., Strickland P., and Trumpbour V. In vivo, cAMP stimulates growth and morphogenesis of mouse mammary ducts. Proc. Natl. Acad. Sci. USA 81 (1984) 4950-4954
6. Stewart P.J., and Webster R.A. Intrauterine injection of cholera-toxin induces estrogen-like uterine growth. Biol. Reprod. 29 (1983) 671-679
7. Aronica S.M., Kraus W.L., and Katzenellenbogen B.S. Estrogen action via the cAMP signaling pathway: Stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc. Natl. Acad. Sci. USA 91 (1994) 8517-8521
8. Demotes-Mainard J., Arnauld E., and Vincent J.D. Estrogens Modulate the Responsiveness of in vivo recorded striatal neurons to iontophoretic application of dopamine in rats: role of D1 and D2 receptor activation. J. Neuroendocrinol. 2 (1990) 825-832
9. Kelly M.J., and Wagner E.J. Estrogen modulation of G-protein-coupled receptors. Trends Endocrinol. Metab. 10 (1999) 369-374
10. Takano K., Asano S., and Yamashita N. Activation of G protein-coupled K+ channels by dopamine in human GH-producing cells. Am. J. Physiol. 266 (1994) E318-E325
11. Wagner E.J., Manzanares J., Moore K.E., and Lookingland K.J. Neurochemical evidence that estrogen-induced suppression of kappa-opioid-receptor-mediated regulation of tuberoinfundibular dopaminergic neurons is prolactin-independent. Neuroendocrinology 59 (1994) 197-201
12. Lagrange A.H., Wagner E.J., Rønnekleiv O.K., and Kelly M.J. Estrogen rapidly attenuates a GABAB response in hypothalamic neurons. Neuroendocrinology 64 (1996) 114-123
13. i-coupled plasma membrane estrogen receptors in immortalized gonadotrophin-releasing hormone neurons. Mol. Endocrinol. 17 (2003) 1792-1804
14. i assays in transfected cells. Methods Enzymol. 238 (1994) 81-94
15. z-alpha, in neurons of brain and retina. J. Neurosci. 10 (1990) 2763-2770
16. Felson D.T., Zhang T., Hannan M.T., Kiel D.P., Wilson P.W., and Anderson J.J. The effect of postmenopausal estrogen therapy on bone density in elderly women. N. Engl. J. Med. 329 (1993) 1141-1146
17. Birge S.J., and Mortel K.F. Estrogen and the treatment of Alzheimer's disease. Am. J. Med. 103 (1997) 36S-45S
18. Sudhir K., and Komesaroff P.A. Clinical review 110: cardiovascular actions of estrogens in men. J. Clin. Endocrinol. Metab. 84 (1999) 3411-3415
19. Chan R.Y.K., Chen W.F., Guo A.D., and Wong M.S. Estrogen-like effects of Ginsenoside Rg1. J. Clin. Endo. Metab. 87 (2002) 3691-3695
20. Hart E.J.I.R. Different growth responses to agents which elevate cAMP in human melanoma cell lines of high and low experimental metastatic capacity. Clin. Exp. Metastasis 7 (1989) 85-95
21. Chen W.F., Lau W.S., Cheung P.Y., Guo D.A., and Wong M.S. Activation of insulin-like growth factor I receptor-mediated pathway by ginsenoside Rg1. Brit. J. Pharmacol. 147 (2006) 542-551
22. Catalano S., Mauro L., Marsico S., Giordano C., Rizza P., Rago V., Montanaro D., Maggiolini M., Panno M.L., and Ando S. Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor α in MCF-7 cells. J. Bio. Chem. 279 (2004) 19908-19915
23. Karas R.H., Gauer E.A., Bieber H.E., Baur W.E., and Mendelsohn M.E. Growth factor activation of the estrogen receptor in vascular cells occurs via a mitogen-activated protein kinase- independent pathway. J. Clin. Invest. 101 (1998) 2851-2861
24. Kato S., Endoh H., Masuhiro Y., Kitamoto T., Uchiyama S., Sasaki H., Masushige S., Gotoh Y., Nishida E., Kawashima H., Metzger D., and Chambon P. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270 (1995) 1491-1494
25. Tortora .G., di Isernia G., Sandomenico C., Bianco R., Pomatico G., Pepe S., Bianco A.R., and Ciardiello F. Synergistic inhibition of growth and induction of apoptosis by 8-chloro-cAMP and paclitaxel or cisplatin in human cancer cells. Cancer Res. 57 (1997) 5107-5111
26. Yan L.Z., Herrmann V., Hofer J.K., and Insel P.A. Adrenergic receptor/cAMP-mediated signaling and apoptosis of S49 lymphoma cells. Am. J. Physiol. Cell Physiol. 279 (2000) C1665-C1674
27. Guillemin M.-C., Raffoux E., Vitoux D., Kogan S., Soilihi H., Lallemand-Breitenbach V., Zhu J., Janin A., Daniel M.-T., Gourmel B., Degos L., Dombret H., Lanotte M., and de Thé H. In vivo activation of cAMP signaling induces growth arrest and differentiation in acute promyelocytic leukemia. J. Exp. Med. 196 (2002) 1373-1380
28. Vintermyr O.K., Boe R., Brustugun O.T., Maronde E., Aakvaag A., and Doskeland S.O. Cyclic adenosine monophosphate (cAMP) analogs 8-Cl- and 8-NH2-cAMP induce cell death independently of cAMP kinase-mediated inhibition of the G1/S transition in mammary carcinoma cells (MCF-7). Endocrinol. 136 (1995) 2513-2520
29. Hirsh L., Dantes A., Suh B.-S., Yoshida Y., Hosokawa K., Tajima K., Kotsuji F., Merimsky O., and Amsterdam A. Phosphodiesterase inhibitors as anti-cancer drugs. Biochem. Pharmacol. 68 (2004) 981-988